News | Breast Density | November 07, 2023

Whiterabbit’s WRDensity is the first FDA-cleared AI-driven breast density product on ACR’s platform

Whiterabbit’s WRDensity is the first FDA-cleared AI-driven breast density product on ACR’s platform

November 7, 2023 — Whiterabbit.ai, an AI-technology company dedicated to making late-stage diseases a rarity, announced its collaboration with the American College of Radiology (ACR) Data Science Institute (DSI) to make its AI-driven breast density software, WRDensity, available on ACR’s AI-LAB platform. WRDensity is the first FDA-cleared, commercial algorithm on the ACR Connect platform alongside 12 investigational models from other parties. 

“Whiterabbit believes that transparency is fundamental to the effective and equitable adoption of artificial intelligence in healthcare,” said Alex Sardiña, M.D., CEO of Whiterabbit. “Collaborating with an organization that has the caliber and integrity of the American College of Radiology advances our goal to significantly expand the reach and adoption of AI applications such as WRDensity for the betterment of patients.” 

Whiterabbit’s WRDensity is an FDA-cleared AI-driven software that helps radiologists more accurately and more consistently assess breast density.1 Consistent assessment of breast density is vital to effective patient management in support of individualized supplemental screening recommendations to a patient.2 

“ACR’s AI-LAB will use WRDensity in its objective to simplify the evaluation and adoption of AI for uses such as breast density assessment. In turn, this could empower radiologists to develop algorithms at their own institutions to meet their unique clinical needs,” said Laura Coombs, vice president of data science and informatics for the ACR DSI. “ACR DSI facilitates the development, validation and implementation of artificial intelligence applications to expand radiologists’ diagnostic and clinical capabilities to improve medical care.” 

For more information: https://whiterabbit.ai/ 

References: 

1 Matthews TP, Singh S, Mombourquette B, Su J, Shah MP, Pedemonte S, Long A, Maffit D, Gurney J, Hoil RM, Ghare N, Smith D, Moore SM, Marks SC, Wahl RL. A Multisite Study of a Breast Density Deep Learning Model for Full-Field Digital Mammography and Synthetic Mammography. Radiol Artif Intell. 2020 Nov 4;3(1):e200015. doi: 10.1148/ryai.2020200015. PMID: 33937850; PMCID: PMC8082294.
2 Whiterabbit.ai. Longitudinal study of AI in breast density to be presented at RSNA. May 11, 2023. Accessed: June 28, 2023. https://www.whiterabbit.ai/ 

Find more RSNA23 conference coverage here


Related Content

News | Cardiac Imaging

Oct. 24, 2025 —YorLabs, Inc., a medical technology company developing next-generation intracardiac imaging solutions for ...

Time October 27, 2025
arrow
Feature | Breast Imaging

Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...

Time October 24, 2025
arrow
News | Computed Tomography (CT)

Oct. 9, 2025 — Harrison.ai has received three FDA Breakthrough Device Designations for CT imaging solutions, further ...

Time October 21, 2025
arrow
News | Contrast Media

Oct. 21, 2025 — Subtle Medical, Inc., a provider of AI-powered medical imaging solutions, has announced positive ...

Time October 21, 2025
arrow
News | Artificial Intelligence

Oct. 20, 2025 — Viz.ai has launched of Viz Assist, a suite of autonomous AI agents that significantly enhance how care ...

Time October 20, 2025
arrow
News | CT Angiography (CTA)

Oct. 9, 2025 — RapidAI recently announced that its Lumina 3D built on the Rapid Enterprise Platform has been named to ...

Time October 16, 2025
arrow
News | Point-of-Care Ultrasound (POCUS)

Oct. 15, 2025 — GE HealthCare has announced the latest advancement in its Venue family of point-of-care ultrasound ...

Time October 16, 2025
arrow
News | Breast Imaging

Oct. 15, 2025 — Leading into Breast Cancer Awareness Month, Fujifilm Healthcare Americas Corp. and Beekley Medical ...

Time October 15, 2025
arrow
News | RSNA 2025

Oct. 7, 2025 — RSNA Ventures, a mission-aligned subsidiary of Radiological Society of North America (RSNA), has ...

Time October 08, 2025
arrow
News | RSNA 2025

Oct. 7, 2025 – Clairity Inc., a leader in AI-based breast cancer risk prediction, will make five scientific ...

Time October 07, 2025
arrow
Subscribe Now